Keywords: astrazeneca, wins, fast-track, review, usa, new, arimidex

AstraZeneca wins fast-track review in USA of new Arimidex use

Article | 22 April 2002

Print This

The US Food and Drug Administration has granted a six-month priorityreview to AstraZeneca's supplemental New Drug Application for the use ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in